Cancer BiologyCancer LettersPeer-reviewed
Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer
Gangyin Zhao, Gabriel Forn‐Cuní, Marvin Scheers…·Ewa B. Snaar-Jagalska
This study shows that targeting both AMPK and mTOR can inhibit prostate cancer metastasis by blocking the metabolic switch required for tumor growth in new environments.
24 citations